With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.
President Donald Trump said delayed 25% tariffs on Mexico and Canada would go into effect on Tuesday. Catch up on MedTech Dive’s latest coverage of Trump’s tariffs.
Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional ...
On Dragon Copilot, Microsoft has said that “healthcare-specific clinical, chat and compliance safeguards for accurate and ...
Ever-expanding applications of robotic surgery platforms allow health care providers to leverage the technology to reduce ...
8h
India Today on MSNStates have failed...: Supreme Court on inflated drug prices in private hospitalsSupreme Court questioned the regulation of private hospital pharmacies, expressing doubts over enforcement while ...
We reduced our fair value estimate to $15.50 per share from $27.20 to account for greater headwinds as a newly stand-alone company since its spinoff from Labcorp in 2023, which will weigh on revenue ...
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...
China and Mexico are two of the largest medical equipment manufacturers in the world. The U.S. has imported roughly $10B in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results